Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU8Q | ISIN: CA74141E1043 | Ticker-Symbol: 18H
Stuttgart
06.06.25 | 08:05
0,024 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PREVECEUTICAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
PREVECEUTICAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0190,03617:20

Aktuelle News zur PREVECEUTICAL MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoPreveceutical Medical Inc: Preveceutical appoints Sampath as corporate adviser5
MoPreveCeutical Medical Inc.: PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor165Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...
► Artikel lesen
26.05.Preveceutical Medical Inc: Preveceutical appoints Glover as corporate adviser2
26.05.PreveCeutical Medical Inc.: PreveCeutical Welcomes Stephen Glover as Corporate Advisor336Vancouver, British Columbia--(Newsfile Corp. - May 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...
► Artikel lesen
23.05.Preveceutical Medical Inc: Preveceutical closes $748,383 private placement3
PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln
22.05.PreveCeutical Medical Inc.: PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement377Vancouver, British Columbia--(Newsfile Corp. - May 22, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, following...
► Artikel lesen
14.05.PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies316Vancouver, British Columbia--(Newsfile Corp. - May 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), a health sciences company that develops innovative...
► Artikel lesen
29.04.Preveceutical Medical Inc: Preveceutical Medical closes first tranche of financing5
28.04.PreveCeutical Medical Inc.: PreveCeutical Closes Initial Tranche of Up-Sized Non-Brokered Private Placement440Vancouver, British Columbia--(Newsfile Corp. - April 28, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, further...
► Artikel lesen
15.04.Preveceutical Medical Inc: Preveceutical further increases placement to $700,0003
15.04.PreveCeutical Medical Inc.: PreveCeutical Announces Up-Sized Non-Brokered Private Placement521Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that, further to its news...
► Artikel lesen
03.04.Preveceutical Medical Inc: Preveceutical increases private placement to $500,0002
03.04.PreveCeutical Medical Inc.: PreveCeutical Announces Update to Non-Brokered Private Placement538Vancouver, British Columbia--(Newsfile Corp. - April 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered...
► Artikel lesen
11.03.Preveceutical Medical Inc: Preveceutical Medical extends private placement4
10.03.PreveCeutical Medical Inc.: PreveCeutical Announces Update to Private Placement580Vancouver, British Columbia--(Newsfile Corp. - March 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that further to its news...
► Artikel lesen
06.02.PreveCeutical Medical Inc.: PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease396Vancouver, British Columbia--(Newsfile Corp. - February 6, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces a program aiming to...
► Artikel lesen
04.02.Preveceutical Medical Inc: Preveceutical appoints Jones to lead Sol-Gel projects3
04.02.PreveCeutical Medical Inc.: Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects285Vancouver, British Columbia--(Newsfile Corp. - February 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), (the "Company" or "PreveCeutical") a health sciences company that...
► Artikel lesen
24.01.PreveCeutical Medical Inc.: PreveCeutical Announces Non-Brokered Private Placement926Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered...
► Artikel lesen
07.01.PreveCeutical Medical Inc.: BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference559Vancouver, British Columbia--(Newsfile Corp. - January 7, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1